We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Sponsors Agree to Independent Reviews of Diabetes Drugs
Sponsors Agree to Independent Reviews of Diabetes Drugs
June 19, 2013
Drugmakers are welcoming an independent review of clinical trial data in response to a request by the American Diabetes Association (ADA) to reexamine safety concerns over incretin-based glucose-lowering drugs to treat Type 2 diabetes.